drugset / Trial / NCT03461458
Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease
Non-randomizedSequentialOpen-labelTreatment
Summary
To determine the safety and feasibility of autologous, culture-expanded adipose-derived (AD) mesenchymal stromal cells (MSCs) in subjects with painful degenerative disc disease (DDD).
Timeline
- Start
- 2018-10-17
- Primary completion
- 2021-02-06
- Completion
- 2021-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Adipose-Derived Mesenchymal Stromal Cells | Cell therapy | 5e+06 cells | Other |
| Subject | Autologous Adipose-Derived Mesenchymal Stromal Cells | Cell therapy | 2e+07 cells | Other |